Pharmacokinetics, Safety and Tolerability of Single Oral or Intravenous Administration of 200 mg Tedizolid Phosphate in Adolescents.
2016
Background:Tedizolid is a novel oxazolidinone antibacterial US FDA approved for treatment of acute bacterial skin and skin structure infections in adults. This study assessed the pharmacokinetics, safety and tolerability of tedizolid phosphate in adolescents (12–17 years old) after administration of
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
34
References
17
Citations
NaN
KQI